Bernstein keeps CHF 3,004 target for Givaudan stock

Published on 10/26/2026 at 16:39 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Givaudan lists an investor presentation for October 29, 2026. Givaudan stock costs EUR 4,270.50 on October 26, 2026 at 4:34 p.m. CEST.

Analyst target and reporting date

Bernstein maintained a Sell rating and a CHF 3,004.00 target on October 20, 2026.
Givaudan lists an investor presentation for October 29, 2026.
Givaudan stock stood at EUR 4,270.50 at Lang & Schwarz on October 26, 2026 at 4:34 p.m. CEST.

Givaudan, CH0010645932, Illustration mit AI erstellt.

Givaudan (ISIN CH0010645932) is trading at EUR 4,270.50 at Lang & Schwarz on October 26, 2026 at 4:34 p.m. CEST. The latest analyst signal came from Bernstein, which maintained a Sell rating and a CHF 3,004.00 price target on October 20, 2026, according to Markets Insider.

Bernstein keeps a cautious view

The Bernstein assessment places the target below the latest SIX quotation of CHF 3,952.00 at 3:22 p.m. CEST on October 26, 2026. The target and the Swiss quotation use different currencies from the Lang & Schwarz euro price, so they are presented separately.

Bernstein's James Hooper maintained the Sell rating in a report released on October 20, 2026. The report said strong third-quarter results and higher company goals did not necessarily guarantee a positive share-price reaction, as reported by t-online.

Investor event follows 2025 figures

Givaudan's investor page lists a Zurich presentation for October 29, 2026. Its most recent full-year key figures show 2025 sales of CHF 7,472 million, EBITDA of CHF 1,751 million, an EBITDA margin of 23.4 percent, net income of CHF 1,071 million and a dividend of CHF 72.00 per share, according to Givaudan.

The 2025 figures provide the operating baseline for the October 29 event. Givaudan identifies Fragrance & Beauty and Taste & Wellbeing as its two core divisions, with the former generating CHF 3,150 million and the latter CHF 2,741 million in the first nine months of 2026, according to the company's investor materials.

Valuation remains the key comparison

Givaudan's trailing P/E was 29.36 on October 26, 2026, while its market capitalization stood at CHF 36.5 billion. The Swiss specialty-chemicals group had a 52-week range of CHF 2,566.00 to CHF 4,015.00 on the same date, placing the SIX quote below that period high.

Price remains in euros

The Lang & Schwarz quote gives German investors a euro-denominated view of the stock during the afternoon session. The home-market figures add valuation and analyst context, but they are not combined with the euro quotation.

Givaudan stock stood at EUR 4,270.50 at Lang & Schwarz on October 26, 2026 at 4:34 p.m. CEST. The further course of trading is shown by the continuously updated real-time quote of Givaudan stock.